Pfizer recalls Levoxyl (levothyroxine sodium tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- What's wrong
- Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
- Products
-
- Levoxyl (levothyroxine sodium tablets
- Company
- Pfizer
- Where it was sold
-
US Nationwide and Puerto Rico
- Units affected
- 134 1000-count bottles
- Status
- Ongoing
Recall Relay is not affiliated with or endorsed by FDA or any agency. Details here are copied from the FDA notice and may lag behind it; the official notice is always the final word.